Search research articles
Contact Us
Filters
Showing results (221-230 of 228) with videos related to
Page
of 23
Sort By:
You have reached the last page of results.
This site can display upto 228 results.
The Lancet. Haematology
|
June 17, 2024
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
Yu Hu, Xiaofan Liu, Hu Zhou, et al.
The Lancet. Oncology
|
August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
The Lancet. Oncology
|
September 23, 2014
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
Jesús F San-Miguel, Vânia T M Hungria, Sung-Soo Yoon, et al.
BMC Cancer
|
October 14, 2023
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial
Zhongjun Xia, Yun Leng, Baijun Fang, et al.
The New England Journal of Medicine
|
May 29, 2026
Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
Cyrille Touzeau, Roberto Mina, Hang Quach, et al.
Cancer Pathogenesis and Therapy
|
July 23, 2025
Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease
Yutong Wang, Qiming Xu, Yuan Li, et al.
The New England Journal of Medicine
|
June 15, 2026
Talquetamab-Daratumumab in Relapsed or Refractory Myeloma
Roberto Mina, Meral Beksac, Paula Rodríguez-Otero, et al.
Heliyon
|
April 24, 2023
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group
Huisheng Ai, Nelson J Chao, David A Rizzieri, et al.
Page
of 23
Search research articles
Search
Showing results (221-230 of 228) with videos related to
Sort By:
Page
of 23
You have reached the last page of results.
This site can display upto 228 results.
The Lancet. Haematology
|
June 17, 2024
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
Yu Hu, Xiaofan Liu, Hu Zhou, et al.
The Lancet. Oncology
|
August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
The Lancet. Oncology
|
September 23, 2014
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
Jesús F San-Miguel, Vânia T M Hungria, Sung-Soo Yoon, et al.
BMC Cancer
|
October 14, 2023
Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial
Zhongjun Xia, Yun Leng, Baijun Fang, et al.
The New England Journal of Medicine
|
May 29, 2026
Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
Cyrille Touzeau, Roberto Mina, Hang Quach, et al.
Cancer Pathogenesis and Therapy
|
July 23, 2025
Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease
Yutong Wang, Qiming Xu, Yuan Li, et al.
The New England Journal of Medicine
|
June 15, 2026
Talquetamab-Daratumumab in Relapsed or Refractory Myeloma
Roberto Mina, Meral Beksac, Paula Rodríguez-Otero, et al.
Heliyon
|
April 24, 2023
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group
Huisheng Ai, Nelson J Chao, David A Rizzieri, et al.
Page
of 23